Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

Attitudes of GPs towards the seasonal flu vaccine in Europe in 2018, by country

In 2018, it was found that the vast majority of general practitioners in the ten European countries surveyed had a high amount of faith in the safety and importance of the seasonal influenza vaccine. In the United Kingdom, 99 percent of GPs said the vaccine was safe and they would recommend the vaccine to their patients, while every GP surveyed in Romania reported that they would recommend the vaccine to their patients.

Share of general practitioners who agree with following statements regarding the seasonal influenza vaccine in selected European countries in 2018

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until October 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

October 2018

Region

Europe

Survey time period

May 18 to June 2, 2018

Number of respondents

1,043 respondents

Special properties

General practitioners

Method of interview

Online survey

Supplementary notes

MMR vaccine refers to the Measles, Mumps and Rubella vaccine.

Data shows the share of GPs in each country 'strongly agreeing' or 'somewhat agreeing' with the statements: 'The seasonal influenza vaccine is important' and 'The season influenza vaccine is safe.' and the share of GPs who responded 'highly likely' or 'somewhat likely' to the question: 'How likely are you to recommend the seasonal influenza vaccine to patients?'

* Total number for the 10 countries shown. Approximately 100 respondents in each country.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Vaccinations in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.